MAPD disenrollment operates through two distinct regulatory pathways: voluntary elections made by the member during CMS-designated enrollment periods, and involuntary removals initiated by the plan under the six specific grounds listed in 42 CFR 422.74. Health plans that mishandle either pathway face CMS sanctions, beneficiary rights violations, and exposure to member appeals. This article covers the legal framework for both pathways, the obligations plans carry at each stage, and the compliance errors most frequently found in CMS audits and grievance records.
Understanding MAPD disenrollment matters beyond individual cases. CMS monitors disenrollment patterns as part of ongoing plan oversight. High voluntary disenrollment rates affect Star Ratings and quality bonuses. Elevated or irregular involuntary disenrollment rates can signal procedural deficiencies that attract audit scrutiny. Plans that treat disenrollment as a transactional back-office function rather than a compliance-critical process consistently perform worse on both counts.
1. MAPD Defined: Why Disenrollment Triggers Two Separate Regulatory Frameworks
A Medicare Advantage Prescription Drug (MAPD) plan integrates Part C (Medicare Advantage managed care) and Part D (prescription drug coverage) into a single product. A beneficiary enrolled in a MAPD plan has both components under one plan contract. When disenrollment occurs, it terminates both simultaneously: the member exits the Part C managed care arrangement and loses the integrated Part D drug benefit at the same time.
The two disenrollment pathways are legally distinct. Voluntary disenrollment is a member right governed by 42 CFR 422.62 and exercisable only during CMS-designated enrollment periods or qualifying Special Enrollment Periods. Involuntary disenrollment is a plan action governed by 42 CFR 422.74 and permitted only on enumerated grounds. Conflating these two frameworks is the most common source of compliance errors in plan disenrollment operations.
| Dimension | Voluntary Disenrollment | Involuntary Disenrollment |
|---|---|---|
| Who initiates | Member | MA organization (or CMS, for contract terminations) |
| Governing regulation | 42 CFR 422.62 | 42 CFR 422.74 |
| Timing constraint | AEP, OEP, or qualifying SEP only | When permitted ground is met; advance written notice required |
| Part D impact | Part D ends; SEP to join PDP may apply depending on period | Part D ends; involuntary loss SEP typically applies |
| Member appeal right | No (member-initiated) | Yes – member may appeal before effective date |
- All disenrollments are logged and categorised as voluntary or involuntary in plan records, with the applicable regulation noted.
- Staff processing disenrollments can distinguish the two pathways and know which regulatory framework applies to each case.
- Part D implications are communicated to members at the point of any disenrollment, regardless of which pathway applies.
- Disenrollment records are retained per applicable CMS record retention guidance, including the basis for each involuntary disenrollment.
2. Voluntary Disenrollment: Enrollment Periods and Member Rights
Voluntary disenrollment from a MAPD plan is a statutory right. Beneficiaries may not be required to remain in a Medicare Advantage plan against their will. CMS designates specific enrollment periods during which members may exercise this right. Outside these periods, a qualifying Special Enrollment Period is required. Plans that attempt to restrict voluntary disenrollment, delay processing, or use retention practices that create friction in the member’s decision are in violation of CMS beneficiary rights requirements.
Annual Enrollment Period (AEP)
Members may switch from one MA or MAPD plan to another, return to Original Medicare (with or without a standalone PDP), or enrol in a MAPD for the first time if eligible. All changes take effect January 1 of the following year. This is the primary annual window for voluntary disenrollment.
Open Enrollment Period (OEP)
MA and MAPD members may make one plan change during OEP: switch to another MA or MAPD plan, or return to Original Medicare. OEP does not independently create a window to enrol in a standalone PDP without also leaving MA coverage. Changes take effect the first day of the following month.
Special Enrollment Periods (SEPs)
SEPs permit plan changes outside standard periods when a qualifying event occurs: moving out of the service area, involuntary loss of the current plan, gaining low-income subsidy (LIS) eligibility, or qualifying for a 5-star plan. Each SEP has specific eligibility criteria and effective date rules under 42 CFR 422.62(b).
- Processing voluntary disenrollment requests submitted outside an enrollment period without verifying whether a qualifying SEP applies.
- Delaying acknowledgment of a disenrollment election beyond the regulatory processing timeframe.
- Advising members that they can join a standalone PDP during OEP when disenrolling from MAPD without also enrolling in another MA plan: this is incorrect and may leave the member without drug coverage.
- Using call scripts or plan materials that discourage or complicate the voluntary disenrollment process, which CMS treats as a beneficiary rights violation subject to enforcement.
3. Involuntary Disenrollment: The Six Grounds Under 42 CFR 422.74
42 CFR 422.74 defines when an MA organisation may or must initiate disenrollment. The grounds are specific and exhaustive. No other ground authorises a plan to remove a member. Plans that process involuntary disenrollments on undocumented, informal, or unenumerated bases are in regulatory violation regardless of the operational justification offered. CMS enforcement actions in this area routinely cite both the improper removal and the absence of required procedural documentation.
Ground 1: Loss of Part A or Part B Entitlement
A beneficiary who loses entitlement to Medicare Part A or Part B is no longer eligible for Medicare Advantage. Disenrollment is required and takes effect aligned with the loss of entitlement. Plans must notify CMS promptly and inform the member of their coverage status and available options.
Ground 2: Permanent Move Outside Service Area
A member who permanently relocates outside the plan’s approved service area is no longer eligible for that plan. Plans should verify the move is permanent rather than temporary. Temporary absence for travel, hospitalisation, or seasonal relocation does not meet this ground. The member gains a SEP to enrol in a plan covering their new location.
Ground 3: Non-Payment of Plan Premium
Where the plan charges a monthly premium, failure to pay after the required grace period permits disenrollment. CMS prescribes grace period and notice requirements. Plans must provide written notice before disenrolling for non-payment and must apply grace period rules consistently across all members. Selective waiver of premiums for some members and not others creates additional compliance exposure.
Ground 4: Fraud or Misrepresentation in Enrollment
Materially false information provided on the enrollment application may support disenrollment. This ground requires documented evidence of the misrepresentation. Suspicion or discrepancies alone are not sufficient. Plans must follow notice and appeals procedures before the disenrollment takes effect, and should involve compliance and legal review for each case under this ground.
Ground 5: Disruptive or Abusive Behaviour
A member whose behaviour jeopardises the safety of plan staff or other enrollees may be disenrolled, but only after documented attempts to address the behaviour and with CMS approval before the effective date. This is the most procedurally demanding ground. Behaviour that is related to a disability is specifically protected: plans must demonstrate they could not reasonably accommodate the member before CMS will approve removal.
Ground 6: Plan Contract Non-Renewal or Termination
When CMS does not renew or terminates a plan’s contract, all enrolled members are disenrolled. This is a contract-level event, not a member-level removal. Affected members receive a SEP to join another plan without penalty. Plans must notify members within the timeframes CMS prescribes for contract non-renewal or termination events, including information about alternative plan options in the service area.
- High cost of care or frequency of healthcare utilisation: CMS explicitly prohibits disenrollment for cost reasons. Plans may not remove a member because their care is expensive.
- Health status, pre-existing condition, or disability: protected under Medicare’s non-discrimination framework.
- Failure to use in-network providers or follow care management recommendations: members retain this right.
- Non-compliance with disease management or wellness programme participation: plans may not condition continued enrolment on participation in optional programmes.
4. Notice Obligations and the Member Appeals Process
Before any involuntary disenrollment takes effect, 42 CFR 422.74 requires the MA organisation to provide written notice to the member. The notice must state the basis for the disenrollment, the proposed effective date, and the member’s right to appeal. CMS has approved notice language requirements that plans must follow. A procedurally defective notice renders the disenrollment invalid even if the underlying ground is legitimate. Plans that skip or shorten the notice process to resolve an operational issue create liability exposure that exceeds the original problem.
Ground Identified and Documented
Plan identifies a condition meeting one of the six permissible grounds and prepares supporting documentation before any action is taken.
Written Notice Issued to Member
CMS-compliant notice sent to the member stating the ground, the proposed effective date, and the member’s right to appeal before disenrollment takes effect.
Notice Period and Appeals Window
The member may file a grievance or appeal. For grounds requiring CMS approval (such as disruptive behaviour), the plan obtains that approval before the effective date.
Disenrollment Effective and Confirmed
If no successful appeal, disenrollment takes effect. CMS is notified. Member receives confirmation with information about SEPs and Part D coverage options.
- Using notice language or templates that omit required elements: the specific ground, the proposed effective date, or the member’s appeal right.
- Issuing notice verbally or by telephone rather than in writing with verifiable delivery.
- Processing the disenrollment before the notice period has elapsed or before required CMS approval is obtained.
- Failing to retain a dated copy of the notice and proof of delivery in the member’s file as part of the disenrollment record.
5. Part D Coverage at Disenrollment: The Gap Most Plans Underestimate
When a beneficiary disenrolls from a MAPD plan, the integrated Part D prescription drug coverage ends at the same moment as the Part C medical coverage. This creates an immediate gap in drug coverage unless the member separately enrols in a standalone Prescription Drug Plan (PDP) or another MAPD. Many beneficiaries do not understand this consequence, and many plan disenrollment processes fail to communicate it clearly. Members left without drug coverage may face late enrollment penalty accumulation under 42 CFR Part 423 if the gap extends beyond 63 days.
| Disenrollment Type | Part D Coverage Status | Member’s Options for Continuity |
|---|---|---|
| Voluntary (AEP) | Ends December 31; new coverage begins January 1 | Enrol in new MAPD or standalone PDP effective January 1 during AEP |
| Voluntary (OEP) | Ends on effective disenrollment date | OEP does not create a standalone PDP window unless also joining another MA plan; member may face a drug coverage gap |
| Involuntary (plan-initiated) | Ends on effective disenrollment date | SEP for involuntary loss of coverage applies: member may join another MAPD or standalone PDP |
| Plan contract termination | Ends when plan contract ends | CMS-designated SEP applies; plan must notify members in advance with information about alternatives in the service area |
- Include a clear Part D impact statement in every disenrollment communication, explaining that integrated drug coverage ends and describing options for continued coverage.
- For involuntary disenrollments, confirm the member has been informed of the involuntary loss SEP and how to use it to avoid a coverage gap.
- Do not advise members disenrolling during OEP that they can join a standalone PDP without also joining another MA plan: this creates a Part D enrollment problem that the member may not discover until they attempt to fill a prescription.
- Track whether members who disenrolled subsequently enrolled in Part D coverage; persistent gaps may indicate systemic failures in disenrollment communication that affect plan quality scores.
6. Disenrollment Patterns as a Compliance and Quality Signal
CMS monitors disenrollment data as part of ongoing plan performance oversight. High voluntary disenrollment rates relative to plan peers signal member dissatisfaction and directly affect Star Ratings, which determine whether plans qualify for quality bonus payments. Irregular or elevated involuntary disenrollment rates attract audit attention, particularly when a pattern of disenrollments clusters around a single ground, a single department, or a specific time period that does not align with enrollment season activity.
- Track voluntary and involuntary disenrollment rates monthly and compare against CMS-published plan peer data each reporting cycle.
- Conduct quarterly file audits of a random sample of involuntary disenrollments: verify that each case has documented grounds, CMS-compliant notice, required approvals, and accurate effective dates.
- Review grievances and appeals related to disenrollment quarterly for patterns that may indicate systemic issues with specific grounds, departments, or processing staff.
- Include disenrollment process controls and audit findings in the annual compliance work plan and report results to the Compliance Committee.
Involuntary Disenrollment Is Strictly Enumerated
42 CFR 422.74 permits plan-initiated disenrollment on six grounds only. Actions taken outside those grounds, without required notice, or without CMS approval where needed are regulatory violations. Cost, utilisation, and health status are never permissible grounds under any circumstances.
Part D Ends When MAPD Ends
The integrated Part D component terminates simultaneously with Part C coverage. Plans must communicate this at every disenrollment and provide members with information about SEPs and standalone PDP options. Members left without drug coverage for more than 63 days may face late enrollment penalties that follow them permanently.
Disenrollment Patterns Are a Compliance Indicator, Not Just a Business Metric
CMS reviews disenrollment data as part of plan oversight. High voluntary disenrollment rates reduce Star Ratings. Irregular involuntary disenrollment patterns attract audit scrutiny. Compliance teams that treat disenrollment monitoring as a core programme component, alongside grievance and appeals review, catch procedural failures before CMS does.
What is the difference between voluntary and involuntary MAPD disenrollment?
Voluntary disenrollment is initiated by the member during a CMS-designated enrollment period (AEP, OEP, or qualifying SEP) under 42 CFR 422.62. Involuntary disenrollment is initiated by the plan under one of the six specific grounds in 42 CFR 422.74. The two pathways have different procedural requirements, notice obligations, and member appeal rights.
When can a MAPD member voluntarily disenroll from their plan?
Members may voluntarily disenroll during the Annual Enrollment Period (October 15 to December 7, effective January 1), the Open Enrollment Period (January 1 to March 31, effective first of following month), or during a qualifying Special Enrollment Period. Outside these windows, a qualifying SEP event is required. Plans may not restrict or delay voluntary disenrollment requests submitted during a valid enrollment period.
What are the six grounds for involuntary MAPD disenrollment?
Under 42 CFR 422.74, plans may initiate disenrollment when a member: (1) loses Part A or Part B entitlement, (2) permanently moves outside the service area, (3) fails to pay plan premiums within the grace period, (4) engaged in fraud or misrepresentation on the enrollment application, (5) exhibits disruptive behaviour that jeopardises staff or member safety after documented remediation attempts and CMS approval, or (6) the plan’s CMS contract is not renewed or is terminated. No other ground is permissible.
Is written notice required before involuntary MAPD disenrollment?
Yes. 42 CFR 422.74 requires the plan to provide written notice to the member before any involuntary disenrollment takes effect. The notice must state the specific ground, the proposed effective date, and the member’s right to appeal. Plans that disenroll a member without proper advance written notice are in regulatory violation regardless of whether the underlying ground was valid.
What happens to Part D drug coverage when a member leaves a MAPD plan?
The integrated Part D prescription drug coverage terminates at the same time as the Part C (Medicare Advantage) coverage. Members must separately enrol in a standalone Prescription Drug Plan (PDP) or another MAPD to maintain drug coverage. Members who are involuntarily disenrolled have a Special Enrollment Period to join another plan. A drug coverage gap exceeding 63 days may result in a permanent late enrollment penalty on future Part D premiums.
Can a plan disenroll a member for high cost or frequent use of healthcare services?
No. CMS explicitly prohibits involuntary disenrollment based on the cost or frequency of a member’s healthcare utilisation, their health status, or any medical condition. These are not among the six permissible grounds in 42 CFR 422.74. A plan that removes a member for cost or utilisation reasons is in violation of Medicare’s non-discrimination requirements and is subject to CMS enforcement action, including civil monetary penalties.
How should compliance teams monitor MAPD disenrollment patterns?
Compliance teams should track voluntary and involuntary disenrollment rates monthly, comparing results against CMS-published plan peer data. Quarterly file audits of a random sample of involuntary disenrollments should verify that each case contains documented grounds, CMS-compliant notice, required approvals, and correct effective dates. Disenrollment-related grievances and appeals should be reviewed for patterns and reported to the Compliance Committee as a standing item in the annual compliance work plan.
Government and Regulatory Sources
- 42 CFR 422.74 – Disenrollment by the MA Organisation – the governing regulation listing all permissible grounds, notice requirements, and prohibited bases for involuntary disenrollment.
- 42 CFR 422.62 – Election Process for Medicare Advantage – enrollment and disenrollment election periods including AEP, OEP, and qualifying SEPs.
- CMS Medicare Managed Care Manual, Chapter 2 – Enrollment and Disenrollment – CMS operational guidance on MA enrollment and disenrollment procedures, notice requirements, and effective date rules.
- CMS Medicare Advantage and Part D Enrollment Data – source for Medicare Advantage plan enrollment figures referenced in this article.
Research and Industry Sources
- 42 CFR Part 423, Subpart B – Eligibility and Enrollment – Part D enrollment and disenrollment rules including the late enrollment penalty framework when members face drug coverage gaps at MAPD disenrollment.
- CMS Medicare Prescription Drug Coverage General Information – guidance on Part D coverage, standalone PDP enrollment, and the interaction between MAPD and standalone drug plan rules.
CMS compliance programme requirements for Medicare Advantage organisations and Part D plan sponsors, including the seven core elements and mandatory oversight expectations.
Annual enforcement data from HHS and DOJ, the patterns that attract fraud and abuse investigations, and what compliance teams in managed care and Part D should monitor.
The statutory and regulatory basis for healthcare compliance programme requirements, including the OIG guidance framework and how it applies to Medicare Advantage plan sponsors.
VelSafe covers Medicare Advantage, Part D, and healthcare regulatory compliance in depth. Explore the full library for plan sponsors, compliance officers, and healthcare administrators.
